Page last updated: 2024-10-31

nafamostat and Diseases, Peripheral Vascular

nafamostat has been researched along with Diseases, Peripheral Vascular in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Urabe, Y1
Ideishi, M1
Sasaguri, M1
Ikeda, M1
Arakawa, K1
Kizaki, Y1
Ueki, Y1
Yoshida, K1
Yano, M1
Matsumoto, K1
Miyake, S1
Tominaga, Y1
Eguchi, K1
Yano, K1

Trials

1 trial available for nafamostat and Diseases, Peripheral Vascular

ArticleYear
Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
    The American journal of cardiology, 1993, Jul-15, Volume: 72, Issue:2

    Topics: Aged; Arteriosclerosis Obliterans; Benzamidines; Chronic Disease; Exercise Test; Female; Femoral Vei

1993

Other Studies

1 other study available for nafamostat and Diseases, Peripheral Vascular

ArticleYear
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:6

    Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin

1999
chemdatabank.com